Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP

Annals of Hematology

Volumn 90, Issue 7, 2011, Pages 797-802

  Yoo, Changhoon ^a   Lee, Dae Ho ^a   Kim, Jeong Eun ^a   Jo, Jungmin ^a   Yoon, Dok Hyun ^a   Sohn, Byeong Seok ^a   Kim, Sang We ^a   Lee, Jung Shin ^a   Suh, Cheolwon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Diffuse large B cell lymphoma; Interim PET; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS AS TOPIC; CYCLOPHOSPHAMIDE; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDNISONE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VINCRISTINE;

EID: 79960247466     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-010-1135-6     Document Type: Article

References (19)

1. M Pfreundschuh L Trumper A Osterborg R Pettengell M Trneny K Imrie D Ma D Gill J Walewski PL Zinzani R Stahel S Kvaloy O Shpilberg U Jaeger M Hansen T Lehtinen A Lopez-Guillermo C Corrado A Scheliga N Milpied M Mendila M Rashford E Kuhnt M Loeffler 2006 CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Lancet Oncol 7 379 391 16648042 10.1016/S1470-2045(06)70664-7 1:CAS:528:DC%2BD28XjvFWlsbw%3D
2. P Feugier A Van Hoof C Sebban P Solal-Celigny R Bouabdallah C Ferme B Christian E Lepage H Tilly F Morschhauser P Gaulard G Salles A Bosly C Gisselbrecht F Reyes B Coiffier 2005 Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte J Clin Oncol 23 4117 4126 15867204 10.1200/JCO.2005.09.131 1:CAS:528:DC%2BD2MXmt1elsr0%3D (Pubitemid 46211317)
3. IS Lossos D Morgensztern 2006 Prognostic biomarkers in diffuse large B-cell lymphoma J Clin Oncol 24 995 1007 16418498 10.1200/JCO.2005.02.4786 1:CAS:528:DC%2BD28Xitl2qtL4%3D (Pubitemid 46638855)
4. J Hermans AD Krol K van Groningen PM Kluin JC Kluin-Nelemans MH Kramer EM Noordijk F Ong PW Wijermans 1995 International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades Blood 86 1460 1463 7632953 1:CAS:528:DyaK2MXnsVCltrY%3D
5. TC Kwee RM Kwee RA Nievelstein 2008 Imaging in staging of malignant lymphoma: a systematic review Blood 111 504 516 17916746 10.1182/blood-2007-07- 101899 1:CAS:528:DC%2BD1cXns1Chug%3D%3D
6. ME Juweid S Stroobants OS Hoekstra FM Mottaghy M Dietlein A Guermazi GA Wiseman L Kostakoglu K Scheidhauer A Buck R Naumann K Spaepen RJ Hicks WA Weber SN Reske M Schwaiger LH Schwartz JM Zijlstra BA Siegel BD Cheson 2007 Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma J Clin Oncol 25 571 578 17242397 10.1200/JCO.2006.08.2305 (Pubitemid 350002965)
7. A Gallamini M Hutchings L Rigacci L Specht F Merli M Hansen C Patti A Loft F Di Raimondo F D'Amore A Biggi U Vitolo C Stelitano R Sancetta L Trentin S Luminari E Iannitto S Viviani I Pierri A Levis 2007 Early interim 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study J Clin Oncol 25 3746 3752 17646666 10.1200/JCO.2007.11.6525 1:CAS:528:DC%2BD2sXhtVeqt7fE (Pubitemid 47372616)
8. A Gallamini L Rigacci F Merli L Nassi A Bosi I Capodanno S Luminari U Vitolo R Sancetta E Iannitto L Trentin C Stelitano S Tavera A Biggi A Castagnoli A Versari M Gregianin E Pelosi P Torchio A Levis 2006 The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease Haematologica 91 475 481 16585014
9. C Haioun E Itti A Rahmouni P Brice JD Rain K Belhadj P Gaulard L Garderet E Lepage F Reyes M Meignan 2005 [18F]fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome Blood 106 1376 1381 15860666 10.1182/blood-2005-01- 0272 1:CAS:528:DC%2BD2MXosVejt7k%3D (Pubitemid 41129604)
10. M Hutchings A Loft M Hansen LM Pedersen T Buhl J Jurlander S Buus S Keiding F D'Amore AM Boesen AK Berthelsen L Specht 2006 FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma Blood 107 52 59 16150944 10.1182/blood-2005-06-2252 1:CAS:528:DC%2BD28XhsVGgsg%3D%3D (Pubitemid 43053523)
11. NG Mikhaeel M Hutchings PA Fields MJ O'Doherty AR Timothy 2005 FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma Ann Oncol 16 1514 1523 15980161 10.1093/annonc/mdi272 1:STN:280:DC%2BD2MrjtlGhtw%3D%3D (Pubitemid 41222425)
12. K Spaepen S Stroobants P Dupont P Vandenberghe J Thomas T de Groot J Balzarini C De Wolf-Peeters L Mortelmans G Verhoef 2002 Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma Ann Oncol 13 1356 1363 12196360 10.1093/annonc/mdf256 1:STN:280:DC%2BD38vjvVGjsQ%3D%3D
13. T Terasawa J Lau S Bardet O Couturier T Hotta M Hutchings T Nihashi H Nagai 2009 Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review J Clin Oncol 27 1906 1914 19273713 10.1200/JCO.2008.16.0861
14. HS Han MP Escalon B Hsiao A Serafini IS Lossos 2009 High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens Ann Oncol 20 309 318 18842613 10.1093/annonc/mdn629 1:STN:280:DC%2BD1M7jtlWltA%3D%3D
15. BD Cheson B Pfistner ME Juweid RD Gascoyne L Specht SJ Horning B Coiffier RI Fisher A Hagenbeek E Zucca ST Rosen S Stroobants TA Lister RT Hoppe M Dreyling K Tobinai JM Vose JM Connors M Federico V Diehl 2007 Revised response criteria for malignant lymphoma J Clin Oncol 25 579 586 17242396 10.1200/JCO.2006.09.2403 (Pubitemid 350002966)
16. CH Moskowitz H Schoder J Teruya-Feldstein C Sima A Iasonos CS Portlock D Straus A Noy ML Palomba OA O'Connor S Horwitz SA Weaver JL Meikle DA Filippa JF Caravelli PA Hamlin AD Zelenetz 2010 Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-Cell lymphoma J Clin Oncol 28 1896 1903 20212248 10.1200/JCO.2009.26.5942 1:CAS:528: DC%2BC3cXmsFyitb0%3D
17. MR Smith 2003 Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance Oncogene 22 7359 7368 14576843 10.1038/sj.onc.1206939 1:CAS:528:DC%2BD3sXotlajuro%3D
18. C Fruchart O Reman N Le Stang D Musafiri S Cheze M Macro O Switsers N Aide M Liegard X Levaltier AM Peny M Leporrier S Bardet 2006 Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative study Leuk Lymphoma 47 2547 2557 17169799 10.1080/10428190600942959 1:CAS:528: DC%2BD2sXitFWiurk%3D (Pubitemid 44932645)
19. L Kostakoglu SJ Goldsmith JP Leonard P Christos RR Furman T Atasever A Chandramouly S Verma P Kothari M Coleman 2006 FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease Cancer 107 2678 2687 17063502 10.1002/cncr.22276 (Pubitemid 44845624)